FBI raids Carmel home of American Senior Communities CEO
The FBI conducted an investigation Tuesday morning at the Carmel home of James Burkhart, CEO of one of the state’s largest providers of nursing home care.
Health Care
Articles
Drug-price increases slow as benefits managers get tough
A new analysis shows attempts by drugmakers to raise prices are being wiped out in negotiations with managers of drug insurance benefits like Express Scripts Holding Co. and CVS Health Corp.
Retail clinics, apps change doctor-patient relationship
A shortage of primary care physicians and emerging alternatives such as retail clinics and smartphone apps are changing the way patients access the U.S. health care system.
AMA: Anthem, Aetna deals threaten competition across nation
The market for health-insurance in the U.S. is already so highly concentrated that pending tie-ups among four of the country’s largest insurers risk hurting both consumers and doctors, the American Medical Association said.
More precise medical codes aim to track quality of care
On Oct. 1, the nation’s physicians and hospitals must start using a massive new coding system to describe your visit on insurance claims so they get paid.
IUPUI receives $1.9M grant for health workforce diversity
The grant will enable researchers at IU's Indianapolis medical campus to develop and implement the IU Health Careers Opportunity Program.
Senior housing planned on key 86th and Meridian corner
A Missouri-based development team wants to build a $10 million senior living center on the last available parcel at one of the north side’s most visible intersections.
Marian starts search for new med school dean
Marian University expects the deans of both its medical and nursing schools to retire in the next two years. So, the small Catholic school is launching a search for replacements.
Experimental osteoporosis drug bests Lilly’s Forteo in study
The experimental medicine, called romosozumab, showed better results than Eli Lilly and Co.’s Forteo after 12 months, Amgen and UCB said in a joint statement Wednesday.
Longtime IU Health leader Evans to retire next year
Daniel Evans Jr. plans to leave his post as president immediately and retire as CEO on May 1. The system’s chief operating officer, Dennis Murphy, will take over as president now and as CEO in the spring.
Novo Nordisk buying 2 DiMarchi-launched drug firms
Calibrium LLC and MB2 LLC, both based in Carmel, have agreed to be sold for undisclosed amounts. They were developing diabetes drugs discovered by the research team of Richard DiMarchi, a chemistry professor at Indiana University.
Lilly wins patent ruling over blockbuster drug Alimta
Eli Lilly and Co. won a court ruling that will keep generic versions of the chemotherapy drug Alimta off the U.S. market until a patent expires in 2022.
YMCA partners with VA for Pike Township center
Although the $10 million Pike Township YMCA has no timetable for completion, officials have pledged to offer extensive services to veterans in conjunction with the Richard L. Roudebush VA Medical Center.
IU School of Dentistry gets OK for $21.6M expansion
The IU Board of Trustees gave unanimous approval to the 45,000-square-foot addition to the school at IUPUI. It is expected to open in 2020.
Regenstrief CEO Tierney to depart for Texas job
Dr. Bill Tierney, who has led the Regenstrief medical informatics research operation for five years, will become chair of the department of population health at the Dell Medical School at the University of Texas at Austin.
Lilly shares jump after positive study of diabetes drug
Lilly’s stock had its biggest intraday gain since 2009 Thursday after it announced trial results that showed Jardiance lowered the risk of heart attacks, stroke and death in a large trial of adults with type 2 diabetes.
Anthem to cover libido pill; other insurers weighing decision
Concerns about serious side effects, including fainting, complicate discussions about whether to cover Sprout Pharmaceuticals' Addyi.
FDA approves female sex pill, but with safety restrictions
The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the blockbuster success of impotence drugs for men.
Indy medical device firm plans 125-job expansion
Catheter Research Inc.—which makes single-use medical devices, such as catheters—plans a $4.8 million expansion that will relocate its headquarters to larger space on the northwest side.
IU eyes clinical trials to boost research success
The new head of research at the Indiana University School of Medicine thinks the institution is missing out on the more than $6 billion spent each year in the United States on clinical trials.